Frazier Life Sciences Management, L.P. Diversified Active

CIK: 0001892134 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 10, 2022

Total Value ($000): $1,059,640 (100.0% shares, 0.0% debt)

Holdings (41)

ARQT ARCUTIS BIOTHERAPEUTICS INC 17.0%
Value ($000) $179,733 Shares 8,434,232 Est. Cost $16.92 Unrealized +21.3%
HILLEVAX INC 9.6%
Value ($000) $101,493 Shares 9,285,682 Est. Cost $10.93 Unrealized
KRYS KRYSTAL BIOTECH INC 6.8%
Value ($000) $71,924 Shares 1,095,407 Est. Cost $62.37 Unrealized -0.3%
MIRM MIRUM PHARMACEUTICALS INC 6.6%
Value ($000) $69,412 Shares 3,566,912 Est. Cost $20.40 Unrealized +15.6%
CHINOOK THERAPEUTICS INC 5.9%
Value ($000) $62,877 Shares 3,595,026 Est. Cost $16.64 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 5.8%
Value ($000) $61,480 Shares 3,195,403 Est. Cost $16.84 Unrealized -1.1%
PHAT PHATHOM PHARMACEUTICALS INC 4.6%
Value ($000) $49,183 Shares 5,827,415 Est. Cost $16.15 Unrealized -36.4%
SIERRA ONCOLOGY INC 4.5%
Value ($000) $47,876 Shares 870,636 Est. Cost $32.05 Unrealized
IMAGO BIOSCIENCES INC 3.8%
Value ($000) $39,785 Shares 2,971,274 Est. Cost $19.27 Unrealized
PCVX VAXCYTE INC 3.7%
Value ($000) $38,894 Shares 1,787,405 Est. Cost $21.85 Unrealized +5.9%
CRNX CRINETICS PHARMACEUTICALS IN 2.5%
Value ($000) $26,386 Shares 1,414,823 Est. Cost $20.24 Unrealized -1.4%
TARS TARSUS PHARMACEUTICALS INC 2.5%
Value ($000) $26,098 Shares 1,787,527 Est. Cost $17.82 Unrealized -15.8%
ALPINE IMMUNE SCIENCES INC 2.4%
Value ($000) $25,409 Shares 2,985,757 Est. Cost $8.97 Unrealized
TRICIDA INC 1.9%
Value ($000) $20,155 Shares 2,082,093 Est. Cost $8.22 Unrealized
COGT COGENT BIOSCIENCES INC 1.8%
Value ($000) $18,889 Shares 2,094,154 Est. Cost $6.96 Unrealized -2.0%
ANAB ANAPTYSBIO INC 1.7%
Value ($000) $18,264 Shares 899,700 Est. Cost $30.26 Unrealized -26.8%
GRACELL BIOTECHNOLOGIES INC 1.6%
Value ($000) $17,114 Shares 3,111,551 Est. Cost $2.33 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 1.5%
Value ($000) $15,470 Shares 1,572,192 Est. Cost $14.37 Unrealized -23.2%
MERUS N V 1.4%
Value ($000) $15,259 Shares 673,979 Est. Cost $26.19 Unrealized
FRAZIER LIFESCIENCES ACQU CO 1.4%
Value ($000) $14,815 Shares 1,501,000 Est. Cost $9.99 Unrealized
REPL REPLIMUNE GROUP INC 1.3%
Value ($000) $14,094 Shares 806,267 Est. Cost $18.60 Unrealized -11.7%
GRITSTONE BIO INC 1.2%
Value ($000) $12,674 Shares 5,237,348 Est. Cost $4.12 Unrealized
ARVN ARVINAS INC 1.1%
Value ($000) $12,010 Shares 285,331 Est. Cost $67.21 Unrealized -25.3%
PASSAGE BIO INC 1.1%
Value ($000) $11,822 Shares 5,009,219 Est. Cost $3.10 Unrealized
VRDN VIRIDIAN THERAPEUTICS INC 1.1%
Value ($000) $11,342 Shares 980,302 Est. Cost $19.21 Unrealized -30.1%
AUTL AUTOLUS THERAPEUTICS PLC 1.0%
Value ($000) $10,604 Shares 3,746,857 Est. Cost $4.17 Unrealized
NTLA INTELLIA THERAPEUTICS INC 1.0%
Value ($000) $10,543 Shares 203,684 Est. Cost $84.72 Unrealized -40.1%
SLN SILENCE THERAPEUTICS PLC 1.0%
Value ($000) $10,442 Shares 881,173 Est. Cost $19.00 Unrealized
TYRA TYRA BIOSCIENCES INC 0.9%
Value ($000) $9,832 Shares 1,375,065 Est. Cost $11.74 Unrealized -32.1%
SUTRO BIOPHARMA INC 0.9%
Value ($000) $9,255 Shares 1,776,479 Est. Cost $8.22 Unrealized
ACRS ACLARIS THERAPEUTICS INC 0.5%
Value ($000) $5,700 Shares 408,329 Est. Cost $13.64 Unrealized +2.7%
CEREVEL THERAPEUTICS HLDNG I 0.5%
Value ($000) $5,348 Shares 202,260 Est. Cost $28.81 Unrealized
TRVI TREVI THERAPEUTICS INC 0.3%
Value ($000) $3,292 Shares 1,171,627 Est. Cost $2.46 Unrealized 0.0%
PARDES BIOSCIENCES INC 0.2%
Value ($000) $2,596 Shares 845,636 Est. Cost $7.22 Unrealized
IMVT IMMUNOVANT INC 0.2%
Value ($000) $2,284 Shares 585,759 Est. Cost $6.23 Unrealized -30.6%
ESSA PHARMA INC 0.2%
Value ($000) $2,183 Shares 692,910 Est. Cost $6.18 Unrealized
IVERIC BIO INC 0.2%
Value ($000) $1,635 Shares 170,000 Est. Cost $16.83 Unrealized
MOLECULAR TEMPLATES INC 0.1%
Value ($000) $1,253 Shares 1,374,047 Est. Cost $3.45 Unrealized
EPIZYME INC 0.1%
Value ($000) $1,087 Shares 739,369 Est. Cost $1.15 Unrealized
APTINYX INC 0.1%
Value ($000) $1,051 Shares 1,883,244 Est. Cost $2.27 Unrealized
NABRIVA THERAPEUTICS PLC 0.0%
Value ($000) $77 Shares 425,650 Est. Cost $0.42 Unrealized